# State Street SPDR MSCI Europe Value UCITS ETF Accum EUR (EVAL)

**Source:** https://fundology.uk/fund/eval · ISIN IE00BSPLC306 · Data: TradingView (LSE closes and returns, delayed), issuer documents and holdings (SPDR), ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 01/10/2026, EVAL (State Street SPDR MSCI Europe Value UCITS ETF Accum EUR, ISIN IE00BSPLC306) closed at £64.29 on the London Stock Exchange. Its ongoing charge is 0.20% a year (about £20 on £10,000). Over the five years to 01/10/2026 its total return was +93.1%, or +50.9% after UK CPIH inflation.

## Summary

State Street SPDR MSCI Europe Value UCITS ETF Accum EUR is an exchange-traded fund (ETF) from SPDR, launched in 2015. It tracks the MSCI Europe Value Exposure Select Index - EUR — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.2% a year — about £20 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£64.29** (01/10/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | EVAL |
| ISIN | IE00BSPLC306 |
| Category | European shares |
| Type | ETF |
| Provider | SPDR |
| Tracks | MSCI Europe Value Exposure Select Index - EUR |
| Income | Accumulating |
| Ongoing charge | 0.20% a year (£20 per £10,000) |
| Fund size | £53.8m |
| Launched | 2015 |
| Domicile | Ireland |

## Past returns (periods to 01/10/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +24.77% | +20.85% | income reinvested |
| 3 years | +73.61% | +56.66% | income reinvested |
| 5 years | +93.07% | +50.93% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Charges compared with similar funds

Ongoing charge of State Street SPDR MSCI Europe Value UCITS ETF Accum EUR 0.20% a year, as of 02/10/2026: 120 of the 225 other European share funds charge more, 19 the same and 86 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.20%** per year
- ISA eligible: yes
- SIPP eligible: yes

## What it holds

As of 30/09/2026, EVAL holds 121 positions, according to the holdings SPDR publishes. The largest is BNP Paribas · Class A at 4.54% of the fund; the ten largest make up 31.6%.

### Top holdings

Largest positions (as of 30/09/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | BNP Paribas · Class A | [BNP](https://fundology.uk/stock/BNP) | 4.54% |
| 2 | British American Tobacco p.l.c | [BATS](https://fundology.uk/stock/BATS) | 3.71% |
| 3 | Banco Bilbao Vizcaya Argentaria | [BBVA](https://fundology.uk/stock/BBVA) | 3.68% |
| 4 | Roche | [RO](https://fundology.uk/stock/RO) | 3.51% |
| 5 | Capgemini | [CAP](https://fundology.uk/stock/CAP) | 3.48% |
| 6 | Dhl | [DHL](https://fundology.uk/stock/DHL) | 2.74% |
| 7 | Barclays | [BARC](https://fundology.uk/stock/BARC) | 2.61% |
| 8 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.57% |
| 9 | Deutsche Bank Aktiengesellschaft | [DBK](https://fundology.uk/stock/DBK) | 2.40% |
| 10 | Rio Tinto | [RIO](https://fundology.uk/stock/RIO) | 2.32% |

Source: SPDR, holdings as published, as of 30/09/2026.

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

Added up from the holdings SPDR publishes, as of 30/09/2026.

| Sector | Weight |
|---|---|
| Financials | 26.8% |
| Industrials | 19.4% |
| Health Care | 13.0% |
| Information Technology | 8.2% |
| Consumer Staples | 7.7% |
| Energy | 5.7% |
| Materials | 5.3% |
| Consumer Discretionary | 5.2% |
| Other sectors | 8.8% |

### By country

Added up from the holdings SPDR publishes, as of 30/09/2026.

| Country | Weight |
|---|---|
| France | 26.1% |
| United Kingdom | 23.7% |
| Germany | 15.7% |
| Switzerland | 8.2% |
| Sweden | 6.8% |
| Spain | 6.7% |
| Netherlands | 4.2% |
| Denmark | 3.4% |
| Other countries | 5.4% |

All 121 holdings: https://fundology.uk/fund/eval/holdings

## Questions people ask

**What is the ongoing charge of EVAL?**

The ongoing charge of EVAL is 0.20% a year — about £20 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of State Street SPDR MSCI Europe Value UCITS ETF Accum EUR 0.20% a year, as of 02/10/2026: 120 of the 225 other European share funds charge more, 19 the same and 86 less (share classes counted once).

**What does EVAL track?**

EVAL tracks the MSCI Europe Value Exposure Select Index - EUR — large and medium-sized European companies.

**Is EVAL accumulating or distributing?**

EVAL is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of EVAL?**

The ISIN of EVAL is IE00BSPLC306. An ISIN identifies one exact share class of a fund; EVAL is its ticker on the London Stock Exchange.

**What does EVAL hold?**

As of 30/09/2026, EVAL holds 121 positions, according to the holdings SPDR publishes. The largest is BNP Paribas · Class A at 4.54% of the fund; the ten largest make up 31.6%. Its ten largest holdings are BNP Paribas · Class A (4.54%), British American Tobacco p.l.c (3.71%), Banco Bilbao Vizcaya Argentaria (3.68%), Roche (3.51%), Capgemini (3.48%), Dhl (2.74%), Barclays (2.61%), Novartis (2.57%), Deutsche Bank Aktiengesellschaft (2.40%) and Rio Tinto (2.32%).

**How has EVAL done after inflation?**

Over the five years to 01/10/2026 EVAL’s total return was +93.1%, or +50.9% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.